Epioxa from Glaukos is the first epithelium-on corneal cross-linking treatment that has been FDA approved in the United ...
Pediatric candidates were predominantly complex, with severe corneal pathology and 6/11 eyes having preexisting glaucoma, ...
The FDA approved an extension of dosing intervals for Eylea HD in patients with diabetic macular edema and wet age-related macular degeneration, Regeneron Pharmaceuticals, Inc. announced.The approval, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results